Skip to main content
SpringerLink
Log in

Liver injury assessment in special populations: challenges remain

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kullak-Ublick GA, et al. Liver safety assessment in special populations (hepatitis B, C, and oncology trials). Drug Safety 37 (Suppl. 1): 57-62, Nov 2014.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Senior JR. Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug Safety 37 (Suppl. 1): 9-17, Nov 2014.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liver injury assessment in special populations: challenges remain. Reactions Weekly 1528, 9 (2014). https://doi.org/10.1007/s40278-014-5016-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-5016-y

Search

Navigation